• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用组织因子靶向磁性纳米探针提高动脉粥样硬化斑块的体内检测。

Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.

机构信息

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430022, PR China; Targeted Biotherapy Key Laboratory of Ministry of Education, Wuhan, Hubei, PR China.

Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, PR China.

出版信息

Acta Biomater. 2019 May;90:324-336. doi: 10.1016/j.actbio.2019.04.014. Epub 2019 Apr 4.

DOI:10.1016/j.actbio.2019.04.014
PMID:30954623
Abstract

Rupture of atherosclerotic plaques causes acute cardiovascular and cerebrovascular pathology. Tissue factor (TF) is a key factor that affects the development of atherosclerotic plaques and the formation of thrombus and thus constitutes a potential target for the detection of atherosclerotic plaques. In this study, the conjugation of the fusion protein 'enhanced green fluorescent protein with the first epidermal growth factor domain' (EGFP-EGF1) and superparamagnetic iron oxide nanoparticles (EGFP-EGF1-SPIONs) was explored for molecular imaging of TF-positive atherosclerotic plaques. EGFP-EGF1-SPIONs showed improved accuracy, superior contrast effects, and better cytocompatibility compared with common contrast agents in the detection of atherosclerotic plaques of apolipoprotein E knockout (ApoE) mice using magnetic resonance imaging. In conclusion, EGFP-EGF1-SPION is a promising TF-targeting nanoprobe to precisely and specifically detect atherosclerotic plaques, which may improve molecular imaging diagnosis of cardiovascular and cerebrovascular events for the comprehensive evaluation of atherosclerosis. STATEMENT OF SIGNIFICANCE: Traditional methods can only display the status of atherosclerosis, but not forecast the progress of lesions efficiently. It remains challenging to evaluate the plaques specifically and sensitively. In this study, we constructed a tissue factor-targeted magnetic nanoprobe to specifically detect plaques by magnetic resonance imaging in vivo, which will improve the diagnostic technology for atherosclerotic plaques and offer molecular level guidance to treat atherosclerosis. Furthermore, this strategy has critical clinical significance on prevention, diagnosis and therapeutic evaluation of cardio-cerebral vascular events.

摘要

动脉粥样硬化斑块的破裂会导致急性心血管和脑血管疾病。组织因子(TF)是影响动脉粥样硬化斑块发展和血栓形成的关键因素,因此构成了动脉粥样硬化斑块检测的潜在靶点。在这项研究中,探索了融合蛋白 '增强型绿色荧光蛋白与第一个表皮生长因子域'(EGFP-EGF1)与超顺磁性氧化铁纳米颗粒(EGFP-EGF1-SPIONs)的缀合,用于 TF 阳性动脉粥样硬化斑块的分子成像。与普通造影剂相比,EGFP-EGF1-SPION 用于载脂蛋白 E 敲除(ApoE)小鼠的磁共振成像检测动脉粥样硬化斑块时,具有更高的准确性、更好的对比效果和更好的细胞相容性。总之,EGFP-EGF1-SPION 是一种有前途的 TF 靶向纳米探针,可精确且特异性地检测动脉粥样硬化斑块,这可能会改善心血管和脑血管事件的分子成像诊断,从而全面评估动脉粥样硬化。

意义声明

传统方法只能显示动脉粥样硬化的状态,但不能有效地预测病变的进展。特异性和敏感地评估斑块仍然具有挑战性。在这项研究中,我们构建了一种组织因子靶向磁共振纳米探针,通过体内磁共振成像特异性地检测斑块,这将提高动脉粥样硬化斑块的诊断技术,并为治疗动脉粥样硬化提供分子水平的指导。此外,该策略对心脑血管事件的预防、诊断和治疗评估具有重要的临床意义。

相似文献

1
Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.利用组织因子靶向磁性纳米探针提高动脉粥样硬化斑块的体内检测。
Acta Biomater. 2019 May;90:324-336. doi: 10.1016/j.actbio.2019.04.014. Epub 2019 Apr 4.
2
Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.靶向分子氧化铁对比剂用于动脉粥样硬化斑块成像。
Nanotheranostics. 2020 May 30;4(4):184-194. doi: 10.7150/ntno.44712. eCollection 2020.
3
CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.用于易损动脉粥样硬化斑块的MRI/光学双模态分子成像的靶向CD40磁性纳米颗粒。
Atherosclerosis. 2023 Mar;369:17-26. doi: 10.1016/j.atherosclerosis.2023.02.008. Epub 2023 Feb 23.
4
Accumulation of Iron Oxide-Based Contrast Agents in Rabbit Atherosclerotic Plaques in Relation to Plaque Age and Vulnerability Features.铁氧化物基对比剂在兔动脉粥样硬化斑块中的积累与斑块年龄和易损性特征的关系。
Int J Nanomedicine. 2024 Feb 20;19:1645-1666. doi: 10.2147/IJN.S430693. eCollection 2024.
5
Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles.活性髓过氧化物酶靶向纳米颗粒对易损性动脉粥样硬化斑块的高灵敏度磁粒子成像。
Theranostics. 2021 Jan 1;11(2):506-521. doi: 10.7150/thno.49812. eCollection 2021.
6
Promoting the Delivery of Nanoparticles to Atherosclerotic Plaques by DNA Coating.通过 DNA 涂层促进纳米颗粒递送至动脉粥样硬化斑块。
ACS Appl Mater Interfaces. 2019 Apr 17;11(15):13888-13904. doi: 10.1021/acsami.8b17928. Epub 2018 Dec 5.
7
Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.应用血管细胞黏附分子-1 和凋亡靶向超顺磁性氧化铁衍生物对动脉粥样硬化斑块进行磁共振成像特征描述的方案制定。
Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):e36-48. doi: 10.1161/ATVBAHA.112.245415. Epub 2012 Apr 19.
8
Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR-μXRF Imaging.通过 LA-ICP-MS 和 SR-μXRF 成像技术测定动脉粥样硬化斑块中磁共振成像对比剂的微观分布。
Mol Imaging Biol. 2021 Jun;23(3):382-393. doi: 10.1007/s11307-020-01563-z. Epub 2020 Dec 7.
9
Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques.载有脂联素的纳米颗粒增强动脉粥样硬化斑块的成像。
Int J Nanomedicine. 2011;6:1279-90. doi: 10.2147/IJN.S18739. Epub 2011 Jun 21.
10
Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI).用于磁共振成像(MRI)的生物化学衍生超顺磁性氧化铁纳米颗粒(SPIONs)造影剂颗粒在动脉粥样硬化斑块中的定位及生物分布。
Biomed Microdevices. 2007 Oct;9(5):719-27. doi: 10.1007/s10544-007-9081-3.

引用本文的文献

1
Nanoparticles as a Novel Platform for Cardiovascular Disease Diagnosis and Therapy.纳米颗粒作为心血管疾病诊断和治疗的新平台。
Int J Nanomedicine. 2024 Aug 27;19:8831-8846. doi: 10.2147/IJN.S474888. eCollection 2024.
2
Magnetic Nanoparticles Mediated Thrombolysis-A Review.磁性纳米颗粒介导的溶栓治疗——综述
IEEE Open J Nanotechnol. 2023;4:109-132. doi: 10.1109/ojnano.2023.3273921. Epub 2023 May 8.
3
Engineering molecular nanoprobes to target early atherosclerosis: Precise diagnostic tools and promising therapeutic carriers.
工程化分子纳米探针靶向早期动脉粥样硬化:精准的诊断工具和有前途的治疗载体。
Nanotheranostics. 2023 Apr 2;7(3):327-344. doi: 10.7150/ntno.82654. eCollection 2023.
4
LIFU-responsive nanomedicine enables acoustic droplet vaporization-induced apoptosis of macrophages for stabilizing vulnerable atherosclerotic plaques.低强度聚焦超声响应性纳米药物可实现声致液滴汽化诱导巨噬细胞凋亡,从而稳定易损性动脉粥样硬化斑块。
Bioact Mater. 2022 Mar 3;16:120-133. doi: 10.1016/j.bioactmat.2022.02.022. eCollection 2022 Oct.
5
Nanotechnology for cardiovascular diseases.用于心血管疾病的纳米技术。
Innovation (Camb). 2022 Feb 2;3(2):100214. doi: 10.1016/j.xinn.2022.100214. eCollection 2022 Mar 29.
6
Iron Oxide Nanoparticles in Regenerative Medicine and Tissue Engineering.再生医学与组织工程中的氧化铁纳米颗粒
Nanomaterials (Basel). 2021 Sep 8;11(9):2337. doi: 10.3390/nano11092337.
7
Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis.纳米材料在动脉粥样硬化治疗和诊断中的最新进展。
Adv Drug Deliv Rev. 2021 Mar;170:142-199. doi: 10.1016/j.addr.2021.01.005. Epub 2021 Jan 9.
8
Evaluation of different commercial antibodies for their ability to detect human and mouse tissue factor by western blotting.通过蛋白质免疫印迹法评估不同商业抗体检测人源和鼠源组织因子的能力。
Res Pract Thromb Haemost. 2020 Jul 6;4(6):1013-1023. doi: 10.1002/rth2.12363. eCollection 2020 Aug.
9
Applications of superparamagnetic iron oxide nanoparticles in drug and therapeutic delivery, and biotechnological advancements.超顺磁性氧化铁纳米颗粒在药物与治疗递送以及生物技术进展中的应用。
Beilstein J Nanotechnol. 2020 Jul 27;11:1092-1109. doi: 10.3762/bjnano.11.94. eCollection 2020.